青光眼滤过手术后1-磷酸鞘氨醇(S1P)相关的人结膜成纤维细胞反应
研究检测青光眼滤过手术前后房水中1-磷酸鞘氨醇(S1P)水平,并观察S1P对人结膜成纤维细胞(HCF)的体外作用。术后滤过泡房水中S1P等溶血磷脂显著升高至生物活性浓度,S1P经S1P2受体促进HCF迁移及肌成纤维细胞分化,S1P2拮抗剂JTE 013可抑制上述反应。
要点
- 滤过手术后滤过泡房水中S1P、脱氢-S1P和鞘氨醇显著升高至生物活性浓度(P < 0.0001)。
- S1P不影HCF增殖,但增强细胞迁移,该作用可被S1P2拮抗剂JTE 013抑制。
- S1P刺激显著增加F-actin、αSMA和胶原表达,JTE 013可减少这些表达。
核心结论
- 滤过手术结束时房水中存在生物活性浓度的S1P,S1P通过S1P2受体激活HCF。
- 这些结果揭示了S1P2拮抗剂在预防青光眼滤过手术后瘢痕形成方面的潜力。
研究设计与样本
- 检测滤过手术前后即刻获取的房水样本中S1P及相关鞘磷脂水平,采用液相色谱-串联质谱法。
- 所有体外实验使用人结膜成纤维细胞(HCF),采用定量实时PCR检测五种S1P受体亚型表达。
- 采用WST-1法和划痕迁移实验分别评估S1P及受体特异性拮抗剂对HCF活力和细胞迁移的影响。
- 通过免疫细胞化学、Western印迹和胶原蓄积实验评估F-actin、α-平滑肌肌动蛋白(αSMA)和胶原表达变化以判断肌成纤维细胞分化和细胞外基质产生。
主要发现
- 手术前即刻房水样本中未检测到显著S1P水平,但术后滤过泡房水中包括S1P、脱氢-S1P和鞘氨醇在内的几种溶血磷脂显著升高至生物活性浓度(P < 0.0001)。
- HCF中检测到三种主要S1P受体亚型的mRNA表达。
- S1P水平不影响HCF增殖,但S1P增强细胞迁移,该作用可被S1P2拮抗剂JTE 013抑制。
- S1P刺激显著增加F-actin、αSMA和胶原表达,JTE 013可减少这些表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate levels of sphingosine-1-phosphate (S1P) in aqueous fluid samples taken before and after filtration surgery and S1P-induced human conjunctival fibroblast (HCF) responses. METHODS: Levels of S1P and its related sphingophospholipids in aqueous fluid obtained immediately before and after filtration surgery were determined by liquid chromatography-tandem mass spectrometry. HCFs were used for all in vitro experiments. The expression of five S1P receptor subtypes in HCFs was examined by quantitative real-time PCR. The effect of S1P and receptor-specific antagonists on HCF viability and cell migration was assessed by WST-1 assay and scratch migration assay, respectively. Differentiation to myofibroblasts and extracellular matrix production was evaluated by examining changes in F-actin, α-smooth muscle actin (αSMA), and collagen expression with immunocytochemistry, Western blotting, and collagen accumulation assay, respectively. RESULTS: No significant S1P levels in the aqueous fluid samples were detectable immediately before surgery, but postoperative levels of several lysophospholipids, including S1P, dehydro-S1P, and sphingosine, were significantly increased to bioactive concentrations in aqueous fluid in the blebs (P < 0.0001). mRNA expression of the three main S1P receptor subtypes was detected in HCFs. Although S1P levels did not influence HCF proliferation, S1P enhanced cell migration, which could be inhibited by the S1P2 antagonist JTE 013. F-actin, αSMA, and collagen expression was significantly increased by S1P stimulation and was reduced by JTE 013. CONCLUSIONS: Bioactive S1P concentrations were present in the aqueous fluid at the end of filtration surgery. S1P activated HCFs via S1P2 receptors. These results revealed the potential of S1P2 antagonists in preventing scarring after glaucoma filtration surgery.
引用
- Aoyama-Araki Y, Honjo M, Uchida T, et al. Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma. Invest Ophthalmol Vis Sci. 2017. PMID: 28418499. doi:10.1167/iovs.16-21288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。